Prefilled Syringes Market By Type (Disposable Prefilled Syringes, Reusable Prefilled Syringes), By Material (Plastic Prefilled Syringes, Glass Prefilled Syringes), By Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis, Others (Biotech Drugs And Vaccines) ) - Growth, Future Prospects, Competitive Analysis And Forecast 2017 - 2025

The World Health Organization in its 2015 research survey has stated that in the last decade due to needle stick injury approximately 2 million healthcare professionals experienced percutaneous exposure to infectious diseases such as Hepatitis B and C virus, and HIV. Earlier, prefilled syringes were featured as add on safety devices, but technological advancement in the design aspect has introduced inbuilt safety mechanism. Unilife Corporation was the first manufacturer to market prefilled syringes with integrated safety features. Manufacturers are presently focusing on developing prefilled syringes with auto retractable needle technology and adopting integrated passive safety mechanism for prefilled syringes needle-stick safety.

The market scope for the report prefilled syringes includes types such as disposable prefilled syringes and reusable prefilled syringes. The materials considered for the report is sub segmented as plastic prefilled syringes and glass prefilled syringes. The application of prefilled syringes is prevalent in major areas such as diabetes, anaphylaxis, rheumatoid arthritis and others (biotech drugs and vaccines).

Prefilled syringes market consists of the geographic segments for five regions along with their respective major countries:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Rest of LATAM
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

In the geography segment the data forecast and market estimation is covered to understand the market trend prevailing in the major countries.

Critical parameters such as product portfolio, geographical presence and inception helps in the determination of top 3 countries and in mapping the currently existing competition in prefilled syringes market. The company profiles suffices us with the latest technology adopted by the premier players and recent merger and acquisition influencing the business milieu of global prefilled syringes market. The manufacturers seeking prime position in the global prefilled syringes market are Bayer Healthcare, Gerresheimer AG, Biocon, Becton, Dickinson & Company, Haselmeier AG, Nipro Medical Corporation, Owen Mumford, SCHOTT, Unilife Corporation and Vetter Pharma International GmbH.

Based on applications, the global prefilled syringes market is categorized into

• Diabetes
• Anaphylaxis
• Rheumatoid Arthritis
• Others (Biotech Drugs and Vaccines)

The conventional syringe vial combination has been replaced by prefilled syringes as they are helpful to healthcare professionals due to the ease of drug injection procedures and time saving. In addition, the decreasing manufacturing cost of prefilled syringes and their increasing demand from homecare and institutional patients for self-injection will drive the prefilled syringes market. Diabetes segment represents the superior share in prefilled syringes market owing to the rising prevalence of diabetes and increasing demand for prefilled insulin syringes for its excellent results in patients suffering with type 1 diabetes. Anaphylaxis segment employs prefilled syringes under emergency situations arisen due to anaphylactic shock reactions. Prefilled syringes are used by the pharmaceutical companies to store biotech drugs and vaccines that have stability issues while transferring them from vials to syringes.

For the purpose of this study, the global prefilled syringes market is categorized into the following regional and country specific markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

The Centers for Disease Control and Prevention has stated in its 2015 report that approximately eighty six percent of the United States annual healthcare expenditures are for the treatment of people suffering with chronic ailments. North America is the leader in global prefilled syringe market as a result of increasing number of citizens suffering with chronic ailments and enhanced spending in the research and development of prefilled syringes. In Europe, increasing demand for prefilled syringes in homecare settings and domicile of key players pioneering in manufacture of vaccines and biosimilars will drive its market. Asia Pacific reflects substantial market opportunity on account of welcoming regulatory environment for prefilled syringes and government spending in developing healthcare infrastructure for the middle- and low-income people to avail medication for chronic ailments. Provision of healthcare aid by agencies such as the World Health Organization and Red Cross, and health awareness campaign conducted by premier player will proliferate the prefilled syringes market in Middle East and Africa and Latin America.

Based on material, the global prefilled syringes market is categorized into

• Plastic Prefilled Syringes
• Glass Prefilled Syringes

Prefilled syringe materials have 2 value additions in healthcare drug delivery: the primary packaging aspects of syringe manufacturing provides assurance that there is no untoward effect on the drug shelf life, strength and purity; and convenience in administering the appropriate amount of the medication to the patient. Glass syringes have advantages such as optical clarity in which medication volumes are read to the point as the plunger is parallel with the calibration in syringe, and possess excellent thermal and chemical resistance properties. The drawbacks associated with glass syringes are breakage, potential surface reactivity, leaching and particulate contamination. Plastic syringes made from cyclic polyolefin resin are gaining tremendous popularity among healthcare professionals. The inherent features of plastic syringes with break resistance, decreased surface reactivity, reduced drug adsorption and compatible with high and low pH drug solutions.